"THE EFFECTS OF LOW DOSE METHYLPHENIDATE ADMINISTRATION ON RISK/REWARD " by Eleni Papadopoulos

Date Approved

6-9-2025

Embargo Period

6-9-2027

Document Type

Dissertation

Degree Name

Ph.D. Neuroscience

Department

Cell Biology and Neuroscience

College

Rowan-Virtua School of Translational Biomedical Engineering & Sciences

Advisor

Rachel Navarra, Ph.D.

Committee Member 1

Daniel Manvich, Ph.D.

Committee Member 2

Jessica Loweth, Ph.D.

Committee Member 3

Elizabeth West-Niedringhaus, Ph.D.

Committee Member 4

Cole Vonder Haar, Ph.D.

Keywords

Catecholamine Transporters;Methylphenidate;Probabilistic Discounting Task;Sex Differences;TBI

Disciplines

Medical Sciences | Medicine and Health Sciences | Neurosciences

Abstract

Repetitive mild traumatic brain injury (rmTBIs) impairs catecholamine (CA) regulation within the prefrontal cortex (PFC)-mediated leading to aberrant higher-order decision making processes. The psychostimulant, methylphenidate (MPH), elevates CA levels by blocking their reuptake transporters. However, to establish a treatment regimen, it is necessary to characterize how chronic therapeutic doses of MPH affect rmTBI-induced disruptions of decision making. Here, we assessed risk/reward decision making for 4 weeks in male and female rodents trained on the probabilistic discounting task (PDT) following rmTBI induced by the closed head-controlled cortical impact model. Rats received daily administration of saline or low-dose MPH beginning 48 hours from final injury through behavioral testing. The combination of rmTBI and MPH treatment significantly increased risky choice preference in males for 2 weeks post-surgery. In contrast, MPH alone disrupted choice behavior in uninjured females within the first week post-surgery. CA transporter protein levels were altered within subregions of the PFC only within the first week following injury, MPH treatment and the combination. These results indicate MPH treatment transiently exacerbates risky behavior and CA transporter protein in males, but not females, following rmTBI. These sex-specific responses advise caution for males exposed to making decisions that involve uncertain risk/reward outcomes when considering MPH to treat post-rmTBI cognitive symptoms.

Available for download on Wednesday, June 09, 2027

Included in

Neurosciences Commons

Share

COinS